Stay updated on Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRemoved related topics 'Prostate cancer' and 'MedlinePlus Genetics' and added the label 'Revision: v3.3.2'. This is a minor UI/content update and does not affect the study details.SummaryDifference0.2%

- Check28 days agoChange DetectedAdded Prostate cancer tag and related topic MedlinePlus Genetics to the page. Removed the government funding status notice.SummaryDifference0.6%

- Check35 days agoChange DetectedRemoved the topic label 'Prostate cancer' and the related topic 'MedlinePlus Genetics' from the page. This could affect topic-based navigation and the visibility of prostate cancer-related information on the study page.SummaryDifference0.2%

- Check42 days agoChange DetectedNo significant content changes detected; only minor visual/UI differences between the two screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check49 days agoChange DetectedRelated topics tags for Prostate cancer and MedlinePlus Genetics were removed from the page.SummaryDifference0.2%

- Check71 days agoChange DetectedUpdated page indicates a new release (v3.2.0) and adds a government operating-status notice regarding NIH Clinical Center, replacing the previous v3.1.0 reference.SummaryDifference3%

Stay in the know with updates to Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial page.